Responses
Immune cell therapies and immune cell engineering
Original research
Development of a compact bidirectional promoter-driven dual chimeric antigen receptor (CAR) construct targeting CD19 and CD20 in the Sleeping Beauty (SB) transposon system
Compose a Response to This Article
Other responses
No responses have been published for this article.
